NASDAQ · GEVO

Gevo, Inc.

$1.63 -$0.21 (-11.20%) 1D After hours

Key Metrics

$445.44M
Market cap
P/E · TTM
$174.42M
Revenue · TTM
−$33.81M
Net income
EPS · TTM $-0.15
Dividend yield
Free cash flow −$43.65M
Beta · 1Y 0.93
EBITDA · TTM $21.59M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 12
    From its Mar 30 high, the share price fell 50%.

    Peak close $2.78 on Mar 30; trough close $1.40 on Jun 12. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -50%
  • Apr 16
    The stock moved -14.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 16
  • Mar 6
    The stock moved +13.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$445.44M
Enterprise value$533.29M
Shares outstanding243.4M
52-wk range$1.12 – $2.97
Avg volume · 20D8.2M
Net cash −$87.85M
Book value / share$1.93
IndustryIndustrial Organic Chemicals
ExchangeNASDAQ
About Gevo, Inc.
IPO dateFeb 9, 2011
Employees151

Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S2.55
P/FCF
EV/EBITDA24.70
EV/Sales3.06
Graham №

Profitability

Gross
Operating -2.9%
Net -19.4%
FCF -25.0%
ROE / ROIC -7.6% · —

Financial Health

Current ratio4.31
Quick ratio3.51
Debt / equity0.37
Debt / EBITDA 7.72
Net cash −$87.85M
Working capital$88.97M

Cash Flow · TTM

Operating CF −$10.49M
Capex −$33.15M
Free cash flow −$43.65M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

-0.1
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings